



下載本文檔
版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemEFPS-ZM1Cat. No.: HY-19370CAS No.: 945714-67-0分式: CHClNO分量: 327.85作靶點(diǎn): Amyloid-作通路: Neuronal Signaling儲(chǔ)存式: Powder -20C 3 years4C 2 yearsIn solvent -80C 6 months-20C 1 month溶解性數(shù)據(jù)體外實(shí)驗(yàn) DMSO : 100 mg/mL (305.02 mM)H2O : 40% PEG300 5%
2、 Tween-80 45% salineSolubility: 2.5 mg/mL (7.63 mM); Suspended solution; Need ultrasonic2. 請(qǐng)依序添加每種溶劑: 10% DMSO 90% (20% SBE-CD in saline)Solubility: 2.5 mg/mL (7.63 mM); Suspended solution; Need ultrasonic1/3 Master of Small Molecules 您邊的抑制劑師www.MedChemE3. 請(qǐng)依序添加每種溶劑: 10% DMSO 90% corn oilSolubility:
3、 2.5 mg/mL (7.63 mM); Clear solutionBIOLOGICAL ACTIVITY物活性 FPS-ZM1親和的 RAGE 抑制劑,Ki 值為 25 nM。IC50 & Target Ki: 25 nM (RAGE) 1體外研究 FPS-ZM1 inhibits A/RAGE binding in CHO cells with approximately 2-fold greater affinity than its parentmolecule, FPS2. FPS-ZM1 inhibits binding of other known RAGE ligands
4、to sRAGE, including S100 calcium-binding protein B and amphoterin. FPS-ZM1 is more effective than FPS2 in reducing A40-induced increasesinBACE1 mRNA and protein levels and the generation of sAPP, an APP cleavage product of BACE1indicative of BACE1 activity 1.體內(nèi)研究 FPS-ZM1 is nontoxic to mice and read
5、ily crossed the blood-brain barrier. In aged APPsw/0 miceoverexpressing human A-precursor protein, a transgenic mouse model of AD with established Apathology, FPS-ZM1 inhibits RAGE-mediated influx of circulating A40 and A42 into the brain. In brain,FPS-ZM1 binds exclusively to RAGE, which inhibits -
6、secretase activity and A production and suppressesmicroglia activation and the neuro-inflammatory response 1. FPS-ZM1 treatment reduces the level of A1-40 and A1-42 in AGEs Rats. It Inhibits AGEs-mediated increase of A-metabolism-related proteins anddownregulates AGEs-mediated increase of pro-inflam
7、matory cytokines in the hippocampus. FPS-ZM1 up-Regulates anti-oxidant defense system and attenuated AGEs induced memory impairment in AGEs rats 2.PROTOCOLKinase Assay 1 Human sRAGE is immobilized (10 g/mL) overnight at 4C in 96-well microtiter plates and blocked with 3%bovine serum albumin. 125I-la
8、beled A40, HMGB1, or S100B at 5 nM in the absence and presence ofvarious concentrations of FPS2 or FPS-ZM1 (10 to 1,000 nM) is added to the wells containing immobilizedsRAGE and incubated for 1 hour at room temperature in PBS. Wells are washed with cold PBS to removeunbound radiolabeled ligands, and
9、 the radioactivity is analyzed 1.MCE has not independently confirmed the accuracy of these methods. They are for reference only.Cell Assay 1 To determine whether FPS2 and FPS-ZM1 are toxic to CHO cells, the cells are treated for 72 hours withdifferent concentrations of inhibitors ranging from 10 nM
10、to 10 M. The cellular toxicity is determined usingthe WST-8 Assay Kit 1.MCE has not independently confirmed the accuracy of these methods. They are for reference only.Animal Rats: Starting from 1 week before intrahippocampal injection, FZM1 and AGEs+FZM1 rats areAdministration 12 intraperitoneally i
11、njected with FPS-ZM1 (1 mg/kg/d at a volume of 2 mL) for 4 weeks; rats in the AGEs andthe control groups are intraperitoneally injected with normal saline with the same volume for 4 weeks. Threeweeks after AGEs intrahippocampal injection, the escape latency time of rats is assayed with Morris water2
12、/3 Master of Small Molecules 您邊的抑制劑師www.MedChemEmaze test, and then all rats are sacrificed 2.Mice: FPS2 or FPS-ZM1 are administered i.v. (1 mg/kg) via the femoral vein and arterial blood samples (30 L) collected at 1, 5, 10, 15, and 20 minutes via the cannulated femoral artery. Plasma is separated
13、bycentrifugation at 4C and immediately stored at -80C until analysis 1.MCE has not independently confirmed the accuracy of these methods. They are for reference only.戶使本產(chǎn)品發(fā)表的科研獻(xiàn) Brain Behav Immun. 2017 Jan;59:322-332. Cell Prolif. 2018 Oct;51(5):e12471 Neurosci Lett. 2018 Nov 1;686:33-40.See more cu
14、stomer validations on HYPERLINK / www.MedChemEREFERENCES1. Deane R, et al. A multimodal RAGE-specific inhibitor reduces amyloid -mediated brain disorder in a mouse model of Alzheimerdisease. J Clin Invest. 2012 Apr;122(4):1377-92.2. Hong Y, et al. Effects of RAGE-Specific Inhibitor FPS-ZM1 on Amyloid- Metabolism and AGEs-Induced Inflammation and OxidativeStress in Rat Hippocampus. Neurochem Res. 2016 May;41(5):1192-9.3. Lian YJ, et al. Ds-HMGB1 and fr-HMGB induce depressive behavior through neuroinflammation in contrast to nonoxid-HMGB1. BrainBehav Immun
溫馨提示
- 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 農(nóng)藥批發(fā)企業(yè)ESG實(shí)踐與創(chuàng)新戰(zhàn)略研究報(bào)告
- 硬脂酸鎂企業(yè)ESG實(shí)踐與創(chuàng)新戰(zhàn)略研究報(bào)告
- 2025年度民辦學(xué)校教職工薪酬結(jié)構(gòu)優(yōu)化與調(diào)整合同
- 二零二五年度兼職業(yè)務(wù)員市場(chǎng)渠道開(kāi)發(fā)與合作合同
- 二零二五年度養(yǎng)殖土地租賃及農(nóng)業(yè)可持續(xù)發(fā)展合作協(xié)議
- 二零二五年度股東對(duì)公司無(wú)息借款及市場(chǎng)風(fēng)險(xiǎn)防范協(xié)議
- 二零二五年度房屋抵押貸款抵押權(quán)爭(zhēng)議解決協(xié)議
- 2025年度現(xiàn)代農(nóng)業(yè)合作入股協(xié)議
- 二零二五年度服務(wù)業(yè)勞動(dòng)合同簽訂與員工培訓(xùn)協(xié)議
- 二零二五年度新員工試用期職業(yè)素養(yǎng)與職場(chǎng)技能提升協(xié)議書(shū)
- 康養(yǎng)建筑設(shè)計(jì)思考
- 《西方經(jīng)濟(jì)學(xué)》說(shuō)課
- 公路施工部署與施工方案的制訂-公路施工部署
- 一例乳腺癌術(shù)后并發(fā)淋巴水腫患者的個(gè)案護(hù)理
- 金婚活動(dòng)策劃方案
- 初中道德與法治中考復(fù)習(xí)策略與方法
- 架空輸電線路無(wú)人機(jī)巡檢系統(tǒng)技術(shù)與應(yīng)用
- 護(hù)眼燈投標(biāo)方案(技術(shù)標(biāo))
- 張愛(ài)玲小說(shuō)中的女性意識(shí)
- 監(jiān)理工作周報(bào)表(范本格式)
評(píng)論
0/150
提交評(píng)論